Daniel Motto
Chief Operating Officer at Enalare Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Herm Cukier | M | 57 |
Enalare Therapeutics, Inc.
 Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | 6 years |
| Joseph Pergolizzi | M | - |
Enalare Therapeutics, Inc.
Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | - |
| Gino Santini | M | 67 |
Enalare Therapeutics, Inc.
Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | - |
| Joseph Petko | M | - |
Enalare Therapeutics, Inc.
Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | - |
| Mark Coleman | M | 56 |
Enalare Therapeutics, Inc.
Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | 3 years |
| Bob Yedid | M | - |
Enalare Therapeutics, Inc.
Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brenton Saunders | M | 56 | 6 years | |
| Scott Giacobello | M | 54 | 7 years | |
| Paul Bisaro | M | 63 | 5 years | |
| David Adam Buchen | M | 59 | 1 years | |
| Hafrun Fridriksdottir | M | 62 | 14 years | |
| Peter John McDonnell | M | 66 | 5 years | |
| Christopher Coughlin | M | 71 | 6 years | |
| Ambrose Bailey | M | 60 | 6 years | |
| C. Nicholson | M | 69 | 6 years | |
| Nesli Basgoz | M | 66 | 6 years | |
| Jonathon Kellerman | M | - | 6 years | |
| John Kelly | M | 57 | 6 years | |
| Sigurdur Olafsson | M | 55 | 4 years | |
| Jirí Michal | M | 71 | 2 years | |
| Andrew L. Turner | M | 77 | 2 years | |
| Robert Todd Joyce | M | 66 | 1 years | |
| George Wilkinson | M | 68 | 1 years | |
| Michael R. Gallagher | M | 77 | 2 years | |
| James H. Bloem | M | 73 | 5 years | |
| Patrick O’Sullivan | M | 82 | 5 years | |
| John A. King | M | 74 | 2 years | |
| Dwight Moxie | M | 48 | 5 years | |
| Jonathan Garen | M | 58 | - | |
| John W. LaRocca | M | 59 | 1 years | |
| Abbey Jenkins | F | - | 2 years | |
| Karah Parschauer | F | 46 | 11 years | |
| Sue-Jean Lin | F | 65 | 26 years | |
| Megan Schoeps | F | 40 | 2 years | |
| Nori Ebersole | F | 60 | 18 years | |
| David Melnick | M | 72 | - | |
| Yao Lee | M | 54 | 4 years | |
| Sailaja Puttagunta | M | 55 | 1 years | |
| Daina Schmidt | F | 62 | 9 years | |
| Ian A. Critchley | M | - | 3 years | |
| Carlos Campoy | M | 60 | 2 years | |
| Kathryn DiMarco | F | 57 | 5 years | |
| Michael Towers | M | - | 5 years | |
| Matthew Moore | M | 51 | 5 years | |
| Kathleen Reape | M | 58 | 1 years | |
| Todd Branning | M | 54 | 3 years | |
| Leonard Dove | M | 51 | 2 years | |
| Karen Ling | F | 60 | 5 years | |
| William Meury | M | 56 | 6 years | |
| Carolyn Myers | M | 66 | 6 years | |
| Charles M. Mayr | M | 67 | 3 years | |
| James D'Arecca | M | 53 | 7 years | |
| Jack Michelson | M | 89 | 1 years | |
| Patrick Spicer | M | - | - | |
| Maria Hilado | F | 59 | 4 years | |
| Richard Spivey | M | 74 | 5 years | |
| James O'Brien | M | 57 | 3 years | |
| William Kane | M | 62 | 7 years | |
| George Brady | M | - | - | |
| Sigurd Kirk | M | 57 | 8 years | |
| Gavin R. Corcoran | M | 61 | 4 years | |
| Michael Rowe | M | 62 | 6 years | |
| Michael Dunne | M | 64 | 1 years | |
| Elisabeth Sandoval | F | 62 | 23 years | |
| Bryan Smith | M | 45 | 7 years | |
| Jeffrey D. Nornhold | M | 58 | 7 years | |
| Paul Navarre | M | - | - | |
| Tina Devries | M | 63 | 1 years | |
| Thomas Nee | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Ireland | 64 | 92.75% |
| United States | 6 | 8.70% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Daniel Motto
- Personal Network
